Jul 14, 2025, 12:32
Anticoagulation in Liver Transplant Candidates: Is Apixaban Safe?
The American Journal of Transplantation shared a post on X:
”Up to 26% of liver transplant candidates have an indication for anticoagulation whilst on the waiting list. Apixaban appears safe to use in the peri-transplant setting for low MELD patients awaiting liver transplantation.”
Title: Safety of apixaban prior to liver transplantation: A single-center Australian case-control study in a population with low scores on the model for end-stage liver disease
Authors: Katrina Tan, Zoe Yang, Elizabeth Low, Jordi Shahab, Jacqueline Balassone, Graham Starkey, Marcos Perini, Lachlan Miles, Adam Testro, Marie Sinclair, Avik Majumdar
Read the full article here.
Stay informed with Hemostasis Today.
-
Nov 6, 2025, 08:24Jacqui McCallum Reflects on Meeting with The Royal Melbourne Hospital Stroke and Neurology Ward Team
-
Nov 6, 2025, 08:17Maxime Dely: The True Heroes of Blood Donation Are Them!
-
Nov 6, 2025, 07:11Francesco Giurazza on Radial Access for Liver Transarterial Chemoembolization
-
Nov 6, 2025, 07:04Andrea Van Beek: Proud to be a Certified Anticoagulation Care Provider (CACP)!
-
Nov 6, 2025, 06:57Jian-Ke Tie’s Team on Comorbidity of VitK-dependent Clotting Factors Deficiency and Chondrodysplasia Punctata
-
Nov 6, 2025, 04:17Aakanksha A To Present Insights from ASH Education Social Media Initiative at 67th ASH Meeting
-
Nov 6, 2025, 04:03Yaping Zhang on Two-Way GPIb-IX Signaling in Platelet Activation and VWF Binding
-
Nov 6, 2025, 03:38Thierry Burnouf on Platelet-Derived Extracellular Vesicles and Their Role in Neurogenesis
-
Nov 6, 2025, 03:29Shubham Misra to Present 3 Abstracts at International Stroke Conference 2026
Nov 6, 2025, 08:17
Nov 5, 2025, 10:45
Nov 5, 2025, 10:43